Joseph David Cesare, USPTO Patent Examiner

Listed by the USPTO as CESARE, JOSEPH DAVID

Tech Center 1600 • Art Units: 1600 1618 1641 1642 1644 1675

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

11.3%

§101 Eligibility

16.0%

§102 Novelty

31.1%

§103 Obviousness

30.2%

§112 Clarity

App #	Title	Status	Assignee
18278998	THERAPEUTIC COMPOSITIONS AND METHODS	Non-Final OA	Johns Hopkins University
18690533	Suppression of Neurodegeneration with Zinc Transporter Protein 7	Non-Final OA	The Regents of the University of California
18282749	COMPOSITIONS AND METHODS FOR TARGETING INFLAMMATORY OR ACTIVATED CELLS AND TREATING OR AMELIORATING INFLAMMATORY CONDITIONS AND PAIN	Non-Final OA	The Regents of the University of California

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Joseph David Cesare examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).